Implanted blood access devices are the foundation of long-term hemodialysis treatment, providing reliable vascular access for repeated procedures. To ensure patient safety and device reliability, these devices must demonstrate blood path integrity — the ability to maintain a secure, unobstructed, and leak-free passage for blood flow throughout their intended lifespan. Any compromise in blood path integrity can lead to leakage, contamination, or treatment inefficiency. That’s why ISO 18193 requires rigorous blood path integrity testing as part of device validation.
At our laboratory, we perform Blood Path Integrity testing in full compliance with ISO 18193, ensuring every device is evaluated under clinically relevant conditions to meet international standards.